Long term ursodeoxycholic acid treatment of cholestatic liver disorders of childhood - Clinical and biochemical effects;LANGFRISTIGE URSODEOXYCHOLSAUREBEHANDLUNG CHOLESTATISCHER LEBERERKRANKUNGEN DES KINDESALTERS - KLINISCHE UND BIOCHEMISCHE EFFEKTE

Klinische Padiatrie

Volumn 208, Issue 3, 1996, Pages 118-122

  Kardorff, Rüdiger ^a   Melter, Michael ^a   Rodeck, Burkhard ^a   Brodehl, Johannes ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biliary atresia; Children; Cholestasis; Pruritus; Ursodeoxycholic acid

Indexed keywords

BILIRUBIN; ENDOGENOUS COMPOUND; GAMMA GLUTAMYLTRANSFERASE; URSODEOXYCHOLIC ACID; CHOLAGOGUE;

ALAGILLE SYNDROME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT ATRESIA; CHILD; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPOPLASIA; INFANT; LIVER INJURY; PRURITUS; RETROSPECTIVE STUDY; BLOOD; BODY HEIGHT; BODY WEIGHT; DRUG EFFECT; FEMALE; FOLLOW UP; INTRAHEPATIC CHOLESTASIS; LIVER FUNCTION TEST; LONG TERM CARE; MALE; PRESCHOOL CHILD;

ALAGILLE SYNDROME; BILIARY ATRESIA; BILIRUBIN; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS, INTRAHEPATIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LIVER FUNCTION TESTS; LONG-TERM CARE; MALE; RETROSPECTIVE STUDIES; URSODEOXYCHOLIC ACID;

EID: 0029665707     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1046459     Document Type: Article

References (23)

1. Balistreri, W. F., H. H. A-Kader, F. C. Ryckman, J. E. Heubi, K. D. R. Setchell, and the UDCA Study Group: Ursodeoxycholic acid therapy in paediatric patients with chronic cholestasis. In: Lentze, M., J. Reichen: Paediatric cholestasis. Novel approaches to treatment. Kluwer Academic Publishers, Dordrecht, NL (1992) 333-344
2. Beuers, U., U. Spengler, W. Kruis, U. Aydemir, B. Wiebecke, W. Heldwein, M. Weinzierl, G. R. Pape, T. Sauerbruch, G. Paumgartner: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 16 (1992) 707-714
3. Bittner, P., H. G. Posselt, T. Sailer, H. Ott, K. Magdorf, U. Wahn, S. Arleth, R. M. Bertele-Harms, A. Wolf, M. Krawinkel, H. Lindemann: The effect of treatment with ursodeoxycholic acid in cystic fibrosis and hepatopathy: results of a placebo-controlled study. In: Paumgartner, G., A. Stiehl, W. Gerok: Bile acids as therapeutic agents: from basic science to clinical practice. Kluwer Academic Publishers, Lancaster (1991) 345-348
4. Calmus, Y., P. Gane, P. Rouger, R. Poupon: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 11 (1990) 12-15
5. Colombo, C., K. D. Setchell, M. Podda, A. Crosignani, A. Roda, L. Curcio, M. Ronchi, A. Giunta A: Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J. Pediatr. 117 (1990) 482-489
6. Cotting, J., M. J. Lentze, J. Reichen: Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut 31 (1990) 918-921
7. Goddard, C. J., T. W. Warnes: Primary biliary cirrhosis: how should we evaluate new treatments? Lancet 343 (1994) 1305-1306
8. Heathcote, E. J., K. Cauch Dudek, V. Walker, R. J. Bailey, L. M. Blendis, C. N. Ghent, P. Michieletti, G. Y. Minuk, S. C. Pappas, L. J. Scully: The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19 (1994) 1149-1156
9. Heuman, D.M., W. M. Pandak, P. B. Hylemon, Z. R. Vlahcevic: Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 14 (1991) 920-926
10. Houwen, R. H. J., N. M. A. Bax: Experiences with ursodeoxycholic acid in biliary atresia. Falk Maastricht Symposion 75 (1994) P25 (Abstract)
11. Kunze, D.: Perzentilkurven von Körpergröße und Körpergewicht 6-14jähriger Kinder. Klin. Päd. 186 (1974) 505
12. Levy, J., A. DeFelice, R. Ramakrishnan, G. Salen, A. Batta, R. Arora: Short term effects of ursodeoxycholic acid (UDCA) in chronic cholestatic disorders of childhood. Gastroenterology 98 (1990) A603
13. Lindor, K. D., E. R. Dickson, W. P. Baldus, R. A. Jorgensen, J. Ludwig, P. A. Murtaugh, J. M. Harrison, R. H. Wiesner, M. L. Anderson, S. M. Lange: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106 (1994) 1284-1290
14. Maggiore, G., C. De Giacomo, F. Bosi, M. Ventura, P. Perotti: Ursodeoxycholic acid treatment of progressive intrahepatic cholestasis of childhood. Falk Maastricht Symposion 75 (1994) P24 (Abstract)
15. Nittono, H., A. Tokita, M. Hayashi, N. Nakatsu, K. Obinata, T. Watanabe, Y. Yamashiro, K. Yabuta, T. Mihyano: Ursodeoxycholic acid in biliary atresia. Lancet 1 (1988) 528
16. Nittono, H., A. Tokita, M. Hayashi, T. Watanabe, K. Obinata, N. Nakatsu, T. Miyano: Ursodeoxycholic acid therapy in the treatment of biliary atresia. Biomed Pharmacother 43 (1989) 37-41
17. Paradis, K., A. Weber: Sudden liver deterioration in infants receiving ursodeoxycholic acid (UDCA). Gastroenterology 102 (1992) A866
18. Poupon, R. E., B. Balkau, E. Eschwege, R. Poupon and the UDCA PBC Study Group: A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N. Engl. J. Med. 324 (1991) 1548-1554
19. Poupon, R. E., R. Poupon, B. Balkau and the UDCA PBC Study Group: Ursodiol for the long-term treatment of primary biliary cirrhosis. N. Engl. J. Med. 330 (1994) 1342-1347
20. Turner, I. B., M. Myszor, H. C. Mitchison, M. K. Bennett, A. D. Burt, O. F. W. James: A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. J. Gastroenterol. Hepatol. 9 (1994) 162-168
21. Simko, V., S. Michael, V. Prego: Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis. Am. J. Gastroenterol. 89 (1994) 392-398
22. Ullrich, D., D. Rating, W. Schröter, F. Hanefeld, J. Bircher: Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation. Lancet 2 (1987) 1324
23. Yoshikawa, M., T. Tsujii, K. Matsumura, J. Yamao, Y. Matsumura, R. Kubo, H. Fukui, S. Ishizaka: Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 16 (1992) 358-364